Pharmacogenomic Study to Predict Neurotoxicity of Oxaliplatin

Clinical trial NCT00977717 · COMPLETED

Trial details

NCT number: NCT00977717
Sponsor: Samsung Medical Center
Status: COMPLETED
Study type: OBSERVATIONAL

Curatively Resected Stage III Colon Cancer

Start date: 2008-09-01
Primary completion: 2010-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.